Treatment strategies for the control and treatment of rheumatoid arthritis

Remission should be the target in the treatment of rheumatoid arthritis (RA) and not low disease activity, while only 5 per cent of RA patients who were followed for 10 years as part of a major study were resistant to biologic therapy, clinicians attending a recent conference were told.